11 results on '"Petroianu, Georg A."'
Search Results
2. Metoclopramide protection of cholinesterase from paraoxon inhibition.
- Author
-
Petroianu GA, Hasan MY, Kosanovic M, Vijayasarathy C, and Saleh AM
- Subjects
- Animals, Erythrocytes enzymology, Humans, Male, Random Allocation, Rats, Acetylcholinesterase metabolism, Cholinesterase Inhibitors toxicity, Cholinesterase Reactivators pharmacology, Erythrocytes drug effects, Metoclopramide pharmacology, Paraoxon toxicity
- Abstract
This study evaluated the protective effect of the benzamide compound metoclopramide (MCP) against inhibition by paraoxon (POX) as assessed by red blood cell acetylcholinesterase (RBC-AChE) activity. Three groups of 6 rats each were used. All substances were applied ip daily for 5 d, followed by a 2-d rest. The 7-d cycle was repeated 6 times. Group 1 received 100 nM POX, Group 2 received 50 microM MCP. Group 3 received 100 nM POX + 50 microM MCP. Red blood cell acetylcholinesterase measurements were performed at base line and then after each 7-d cycle. Enzyme activities were compared using the Mann-Whitney rank order test. Metoclopramide conferred significant in vivo protection from inhibition of RBC-AChE by POX.
- Published
- 2003
3. Intravenous pyruvic acid application in minipigs partially protects acetylcholine-esteratic but not butyrylcholine-esteratic activity in plasma from inhibition by paraoxon.
- Author
-
Petroianu GA, Ewald V, Thyes C, Missler A, and Maleck WH
- Subjects
- Animals, Cholinesterase Reactivators administration & dosage, Drug Antagonism, Female, In Vitro Techniques, Injections, Intravenous, Lactic Acid blood, Pyruvic Acid administration & dosage, Substrate Specificity, Swine, Acetylcholinesterase blood, Butyrylcholinesterase blood, Cholinesterase Inhibitors toxicity, Cholinesterase Reactivators pharmacology, Paraoxon toxicity, Pyruvic Acid pharmacology, Swine, Miniature
- Abstract
Intoxications with organophosphorus compounds such as paraoxon (POX) are frequent. Oximes are the only enzyme reactivators clinically available. In vitro and in vivo studies have shown that l-lactate reduces the inhibition of plasma acetylcholine-esteratic activity (AChEA) (in vitro and in vivo) and plasma butyrylcholine-esteratic activity (BChEA) (at least in vitro and possibly in vivo) by POX. However, a short infusion of 10 g of lactate was unable to elevate the plasma lactate level for >3 h. In this study we tested a substance related to l-lactate, i.e. pyruvic acid. The purpose of this animal experimental study (female minipigs with historical control group) was to determine in vivo whether intravenous (i.v.) pyruvic acid application under normoxic/normocapnic/normohydrogenaemic conditions is able to elevate blood lactate levels and whether it is able to protect AChEA and BChEA from POX inhibition. Animals were anaesthetized, intubated and mechanically ventilated. Each received 1 mg kg(-1) body wt. of POX in 50 ml of saline over 50 min and 10 g (ca. 0.5 g kg(-1) body wt.) of i.v. pyruvic acid in 50 ml of saline over 50 min. They were compared with a historical control group of six animals that received only 1 mg kg(-1) body wt. of POX in 50 ml of saline over 50 min. In central venous blood measurements of plasma AChEA and BChEA, the measurements were performed before (baseline), immediately after POX (50 min after start) and 110, 170, 230, 290, 530 and 1010 min after the start of infusion. A 10 g aliquot of i.v. pyruvic acid had a statistically significant protective effect in vivo on AChEA but not on BChE activity. Further study of the in vivo effects of pyruvic acid and l-lactate after paraoxon intoxication and a formal comparison with standard oxime therapy seems warranted. Also, a combination therapy with l-lactate and pyruvic acid in vivo should be investigated., (Copyright 2003 John Wiley & Sons, Ltd.)
- Published
- 2003
- Full Text
- View/download PDF
4. Intravenous L-lactate application in minipigs partially protects acetylcholinesteratic but not butyrylcholinesteratic activity in plasma from inhibition by paraoxon.
- Author
-
Maleck WH, Kern N, Beha U, Roth C, Rüfer R, and Petroianu GA
- Subjects
- Animals, Female, Injections, Intravenous, Swine, Miniature, Acetylcholinesterase drug effects, Acetylcholinesterase metabolism, Butyrylcholinesterase drug effects, Butyrylcholinesterase metabolism, Cholinesterase Inhibitors pharmacology, Lactic Acid administration & dosage, Paraoxon pharmacology
- Abstract
Objective: Intoxications with organophosphorous compounds such as paraoxon, an inhibitor of serine hydrolases, mainly butyrylcholinesterase and acetylcholinesterase, are frequent. Oximes are the only enzyme reactivators clinically available. In vitro studies have shown that L(+)-lactate reduces the inhibition of acetylcholinesteratic (AChEA) and butyrylcholinesteratic activity of plasma (BChEA) by paraoxon., Design: The purpose of this in vivo study was to determine whether intravenous L(+)-lactate application under normoxic/normocapnic/normohydrogenemic conditions is able to protect AChEA and BChEA from paraoxon inhibition., Setting: University research institute., Subjects: Eighteen female minipigs., Interventions: Animals were anesthetized, intubated, and mechanically ventilated. Every animal received 1 mg of paraoxon per kilogram of body weight in 50 mL of saline over 50 mins. In addition to receiving paraoxon, six pigs of 18 received 2.5 g (0.125 g kg-1 of body weight) of intravenous L(+)-lactate in 50 mL of saline over 50 mins, and six other pigs received 10 g of L(+)-lactate (0.5 g kg-1 of body weight), whereas the six remaining served as controls., Measurements and Main Results: In central venous blood, plasma acetylcholinesteratic and butyrylcholinesteratic activity were measured before paraoxon (baseline, 0 mins), immediately after paraoxon (50 mins after start), and 110, 170, 230, 290, 530, and 1010 mins after the start of infusion. Although 10 g of intravenous L(+)-lactate application had a statistically significant protective effect in vivo on AChEA, 2.5 g did not. No significant protective effect on BChEA was achieved with either 2.5 g or 10 g of L(+)-lactate., Conclusions: Ten grams of L(+)-lactate can increase AChEA when administered simultaneously with paraoxon. Further study of the in vivo effects of L(+)-lactate after paraoxon intoxication and a formal comparison with standard oxime therapy seem warranted. Also, methods for achieving a prolonged elevated lactate concentration in vivo should be investigated.
- Published
- 2002
- Full Text
- View/download PDF
5. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review.
- Author
-
Lorke, Dietrich E. and Petroianu, Georg A.
- Subjects
ORGANOPHOSPHORUS compounds ,ACETYLCHOLINESTERASE ,PESTICIDES ,PHYSOSTIGMINE ,RANITIDINE - Abstract
Organophosphorus compounds (OPCs), inhibitors of acetylcholinesterase (AChE), are useful agents as pesticides, but also represent a serious health hazard. Standard therapy with atropine and established oxime‐type enzyme reactivators (pralidoxime, obidoxime) is unsatisfactory. Better therapeutic results are obtained, when reversible AChE inhibitors are administered before OPC exposure. This review summarizes the history of such a pretreatment approach and sums up a set of experiments undertaken in search of compounds that are efficacious when given before a broad range of OPCs. The prophylactic efficacy of 10 known AChE inhibitors, either already used clinically for different indications (physostigmine, pyridostigmine, ranitidine, tiapride, tacrine, amiloride, metoclopramide, methylene blue) or developed for possible therapeutic use in the future (7‐methoxytacrine, K‐27) was compared, when administered before exposure to six chemically diverse OPCs in the same experimental setting: ethyl‐paraoxon, methyl‐paraoxon, diisopropylfluorophosphate, terbufos sulfone, azinphos‐methyl and dicrotophos. The experimental oxime K‐27 was the most efficacious compound, affording best protection, when administered before terbufos sulfone, azinphos‐methyl and dicrotophos, second best before ethyl‐ and methyl‐paraoxon exposure and third best before diisopropylfluorophosphate administration. This ranking was similar to that of physostigmine, which was superior to the Food and Drug Administration‐approved pretreatment for soman with pyridostigmine. Tiapride, amiloride, metoclopramide, methylene blue and 7‐methoxytacrine did not achieve protection. No correlation was observed between the IC50 of the reversible AChE inhibitors and their protective efficacy. These studies indicate that K‐27 can be considered a very promising broad‐spectrum prophylactic agent in case of imminent organophosphate exposure, which may be related to its AChE reactivating activity rather than its AChE inhibition. Organophosphorus inhibitors of acetylcholinesterase (OPCs) represent a serious health hazard. Standard oxime therapy is unsatisfactory. Reversible cholinesterase inhibitors administered before OPC exposure achieve better results. This review describes the history of such a pretreatment approach and summarizes experiments undertaken in search of compounds that are efficacious when given before a broad range of OPCs. These studies indicate that the experimental oxime K‐27 is a very promising broad‐spectrum prophylactic agent, which may be related to its AChE reactivating capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium
- Author
-
Fernandez-Cabezudo, Maria J, Lorke, Dietrich E, Azimullah, Sheikh, Mechkarska, Milena, Hasan, Mohammed Y, Petroianu, Georg A, and al-Ramadi, Basel K
- Subjects
Lipopolysaccharides ,Male ,Salmonella typhimurium ,Cholinesterase Reactivators ,Erythrocytes ,T-Lymphocytes ,Cell Count ,Pyridinium Compounds ,Thymus Gland ,GPI-Linked Proteins ,Nitric Oxide ,Paraoxon ,Mice ,Oximes ,Concanavalin A ,Animals ,B-Lymphocytes ,Mice, Inbred BALB C ,Macrophages ,Original Articles ,Survival Analysis ,Immune System ,Salmonella Infections ,Acetylcholinesterase ,Cytokines ,Cholinesterase Inhibitors ,Lymph Nodes ,Spleen - Abstract
The cholinergic nervous system has been demonstrated to attenuate the inflammatory response during sepsis via the inhibitory action of acetylcholine (ACh) on macrophages. These findings were largely based on experimental sepsis models using endotoxin as the inducing agent. Herein, however, we report that the specific inhibition of acetylcholinesterase (AChE) renders animals more resistant to infection by a virulent strain of Salmonella enterica serovar Typhimurium, a Gram-negative enteric pathogen. Inhibition of AChE was induced by a subchronic exposure to paraoxon, a potent anti-cholinesterase metabolite of the organophosphorous compound parathion. Our findings indicate that inhibition of AChE enhanced survival of infected mice in a dose-dependent fashion and this correlated with efficient control of bacterial proliferation in target organs. Immunologically, inhibition of AChE enabled the animals to mount a more effective inflammatory anti-microbial response, and to secrete higher levels of interleukin-12, a key T helper type 1-promoting cytokine. The ACh-induced enhancement in resistance to infection was abrogated by co-administration of an oxime which can reactivate AChE. Hence, in a model of Gram-negative bacterial infection, cholinergic stimulation is shown to enhance the anti-microbial immune response leading to effective control of bacterial proliferation and enhanced animal survival.
- Published
- 2010
7. Sub-chronic exposure to paraoxon neither induces nor exacerbates diabetes mellitus in Wistar rat.
- Author
-
Nurulain, Syed M., Petroianu, Georg, Shafiullah, Mohamed, Kalász, Huba, Oz, Murat, Saeed, Tariq, Adem, Abdu, and Adeghate, Ernest
- Subjects
PARAOXON ,DIABETES ,ACETYLCHOLINESTERASE ,HYPERGLYCEMIA ,LABORATORY rats - Abstract
ABSTRACT There is an increasing belief that organophosphorus compounds (OPCs) impair glucose homeostasis and cause hyperglycemia and diabetes mellitus. The present study was undertaken to investigate the putative diabetogenic effect of sub-lethal and sub-chronic exposure to paraoxon (POX), an extremely hazardous OPC used in pesticides. The effect of paraoxon on streptozotocin-induced diabetic rats was also examined. Each rat was injected with 100 nmol of POX 5 days per week for 6 weeks. Blood glucose levels and red blood cell acetylcholinesterase activity were measured weekly. Biochemical analysis and morphological studies were performed at the end of the experiment. The results revealed that POX neither induces nor exacerbates diabetes mellitus in experimental rats. Liver and kidney/body weight ratios revealed statistically insignificant differences when compared with controls. Biochemical analysis of urine samples showed a small but not significant increase in protein level in all groups. Urine bilirubin was significantly higher in the diabetes + POX group when compared with the control group. The number of blood cells in urine was significantly higher in the POX-treated group compared with the control group. Hyperglycemia was noted in the diabetes and diabetes + POX groups, but neither in the saline control nor in POX-treated normal rats. Electron microscopy of POX-treated pancreas did not show any morphological changes in beta cells. These results suggest that POX does not cause diabetes mellitus at sub-lethal sub-chronic exposure. Copyright © 2012 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
8. Pralidoxime and l-Lactate Effects in vitro on the Inhibition of Acetylcholinesterase by Paraoxon: Pralidozime Does Not Confer Superior Protection.
- Author
-
Petroianu, Georg, Roth, Christina, Beha, Ulrike, Fisher, Joseph, Bergler, Wolfgang, and Rüfer, Roderich
- Subjects
ORGANOPHOSPHORUS compounds ,ACETYLCHOLINESTERASE - Abstract
Evaluates the effect of pralidoxime (PRX) and lactate on the inhibition of acetylcholinesterase by paraoxon. Enzyme pseudo-activity; Interaction between PRX and acetylthiocholine substrate; Protective effect of PRX.
- Published
- 2001
- Full Text
- View/download PDF
9. Λ-Lactate Protects in vitro Acetylcholinesterase (AChE) from Inhibition by Paraoxon (E 600).
- Author
-
Petroianu, Georg, Beha, Ulrike, Roth, Christina, Bergler, Wolfgang, and Rüfer, Roderich
- Subjects
LACTATES ,ACETYLCHOLINESTERASE - Abstract
Evaluates the effect of lactate on the inhibition of acetylcholinesterase (AChE) by paraoxon. Prevention of AChE inhibition by lactate; Factors affecting the protective effect of lactate; Inhibition of AChE activity by lactate.
- Published
- 2000
- Full Text
- View/download PDF
10. IN SILICO AND IN VITRO EVALUATION OF TWO NOVEL OXIMES K456 AND K733 AGAINST PARAOXON INHIBITED HUMAN ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE.
- Author
-
Nurulain, Syed M., Fatmi, M. Qaiser, Iqbal, Amna, Malik, Shahrukh, Kalasz, Huba, Musilek, Kamil, Kuca, Kamil, and Petroianu, Georg
- Subjects
OXIMES ,PARAOXON ,ACETYLCHOLINESTERASE ,BUTYRYLCHOLINESTERASE ,ORGANOPHOSPHORUS compounds - Abstract
Organophosphorus compounds (OPs) irreversibly inhibit cholinesterases: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). There is wide variety of applications of OP compounds including warfare chemicals and pesticides. Oxime-type reactivators are used to reactivate the OP inhibited AChE and BChE. Present study was aimed to evaluate the reactivation potency of two novel oximes K456 and K733 against organophosphate inhibited AChE and BChE. Efficacy was compared with K27 and pralidoxime (2-PAM). Molecular mechanism of reactivation by the oximes is predicted by In silico method. Intrinsic toxicity of novel oximes in term of IC50 and 50% reactivation of inhibited enzymes (R50) were evaluated by in vitro methods using human RBC-AChE and plasma BChE. In silico study revealed lower free binding energies, but novel oximes did not bind with catalytic anionic site of enzymes. In vitro studies showed higher intrinsic toxicity by K456 and K733 than K27 and pralidoxime. R50 for human RBC-AChE were K456=203.59µM±66.96; K733= 405.55µM±67.36; K27=2.68µM ±0.98 and pralidoxime 30.71µM±5.10 (mean±SEM) respectively. No substantial reactivation in BChE was noted by tested concentration of novel oximes. The study concludes that oximes with peripheral binding/far from catalytic anionic site are ineffective reactivators. K27 with central (inside the active gorge) binding was superior to all tested oximes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
11. Novel bis-pyridinium oximes with peripheral binding are inferior reactivators of RBC acetylcholinesterase.
- Author
-
Nurulain, Syed, Chaudhry, Maria, Fatmi, Muhammad, Iqbal, Amna, Musilek, Kamil, Kuca, Kamil, and Petroianu, Georg
- Subjects
- *
ACETYLCHOLINESTERASE , *PYRIDINIUM compounds - Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.